ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 168 filers reported holding ASCENDIS PHARMA A/S in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,937,878 | +14.7% | 672,126 | +9.3% | 0.02% | +21.4% |
| Q2 2023 | $54,863,135 | -20.9% | 614,713 | -4.9% | 0.01% | -26.3% |
| Q1 2023 | $69,324,163 | -14.1% | 646,560 | -2.2% | 0.02% | -20.8% |
| Q4 2022 | $80,701,794 | +30.3% | 660,786 | +10.1% | 0.02% | +20.0% |
| Q3 2022 | $61,959,000 | +12.5% | 600,023 | +1.2% | 0.02% | +17.6% |
| Q2 2022 | $55,094,000 | -53.8% | 592,655 | -41.7% | 0.02% | -43.3% |
| Q1 2022 | $119,365,000 | -11.5% | 1,017,090 | +1.4% | 0.03% | -9.1% |
| Q4 2021 | $134,939,000 | -17.6% | 1,003,043 | -2.4% | 0.03% | -19.5% |
| Q3 2021 | $163,736,000 | +7.4% | 1,027,262 | -11.4% | 0.04% | +7.9% |
| Q2 2021 | $152,469,000 | +61.1% | 1,159,024 | +57.8% | 0.04% | +52.0% |
| Q1 2021 | $94,636,000 | -26.0% | 734,292 | -4.2% | 0.02% | -32.4% |
| Q4 2020 | $127,871,000 | +7.9% | 766,704 | -0.1% | 0.04% | -7.5% |
| Q3 2020 | $118,462,000 | +32.9% | 767,639 | +27.3% | 0.04% | +25.0% |
| Q2 2020 | $89,155,000 | +33.2% | 602,805 | +1.4% | 0.03% | +14.3% |
| Q1 2020 | $66,937,000 | -18.9% | 594,421 | +0.2% | 0.03% | +7.7% |
| Q4 2019 | $82,543,000 | -15.9% | 593,323 | -41.8% | 0.03% | 0.0% |
| Q3 2019 | $98,111,000 | -16.0% | 1,018,592 | +0.4% | 0.03% | -13.3% |
| Q2 2019 | $116,802,000 | +1000.5% | 1,014,346 | +1024.8% | 0.03% | +650.0% |
| Q1 2019 | $10,614,000 | +17.5% | 90,177 | -37.4% | 0.00% | +33.3% |
| Q4 2018 | $9,030,000 | -12.1% | 144,139 | -0.6% | 0.00% | 0.0% |
| Q3 2018 | $10,271,000 | +1.4% | 144,956 | -4.8% | 0.00% | 0.0% |
| Q2 2018 | $10,132,000 | – | 152,306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |